Status:
COMPLETED
Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Barrett's Esophagus
Eligibility:
All Genders
Phase:
NA
Brief Summary
The specific aim of this study is to determine the accuracy of Optical Coherence Tomography (OCT) imaging for screening and diagnosis of the distal esophagus in patients undergoing a clinical esophago...
Detailed Description
Three hundred consenting patients undergoing routine esophagogastroduodenoscopy (EGD) procedures will be recruited for examination at the gastroesophageal junction with our developed OCT imaging syste...
Eligibility Criteria
Inclusion
- over the age of 18,
- capable of giving informed consent,
- are undergoing elective EGD, and
- if female are willing to take a pregnancy test
Exclusion
- patients on oral anticoagulation medications,
- with a history of hemostasis disorders and
- patients that are pregnant
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 16 2011
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT01401699
Start Date
September 1 2006
End Date
November 16 2011
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachussetts General Hospital
Boston, Massachusetts, United States, 02114